Abstract

<div>Abstract<p><b>Background:</b> Terminal duct lobular units (TDLU) are the predominant source of breast cancers. Lesser degrees of age-related TDLU involution have been associated with increased breast cancer risk, but factors that influence involution are largely unknown. We assessed whether circulating hormones, implicated in breast cancer risk, are associated with levels of TDLU involution using data from the Susan G. Komen Tissue Bank (KTB) at the Indiana University Simon Cancer Center (2009–2011).</p><p><b>Methods:</b> We evaluated three highly reproducible measures of TDLU involution, using normal breast tissue samples from the KTB (<i>n</i> = 390): TDLU counts, median TDLU span, and median acini counts per TDLU. RRs (for continuous measures), ORs (for categorical measures), 95% confidence intervals (95% CI), and <i>P</i><sub>trends</sub> were calculated to assess the association between tertiles of estradiol, testosterone, sex hormone–binding globulin (SHBG), progesterone, and prolactin with TDLU measures. All models were stratified by menopausal status and adjusted for confounders.</p><p><b>Results:</b> Among premenopausal women, higher prolactin levels were associated with higher TDLU counts (RR<sub>T3vsT1</sub>:1.18; 95% CI: 1.07–1.31; <i>P</i><sub>trend</sub> = 0.0005), but higher progesterone was associated with lower TDLU counts (RR<sub>T3vsT1</sub>: 0.80; 95% CI: 0.72–0.89; <i>P</i><sub>trend</sub> < 0.0001). Among postmenopausal women, higher levels of estradiol (RR<sub>T3vsT1</sub>:1.61; 95% CI: 1.32–1.97; <i>P</i><sub>trend</sub> < 0.0001) and testosterone (RR<sub>T3vsT1</sub>: 1.32; 95% CI: 1.09–1.59; <i>P</i><sub>trend</sub> = 0.0043) were associated with higher TDLU counts.</p><p><b>Conclusions:</b> These data suggest that select hormones may influence breast cancer risk potentially through delaying TDLU involution.</p><p><b>Impact:</b> Increased understanding of the relationship between circulating markers and TDLU involution may offer new insights into breast carcinogenesis. <i>Cancer Epidemiol Biomarkers Prev; 23(12); 2765–73. ©2014 AACR</i>.</p></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.